About Dominic Galante, MD, MBA, Chief Medical Officer, Precision for Value

This author has not yet filled in any details.
So far Dominic Galante, MD, MBA, Chief Medical Officer, Precision for Value has created 2 blog entries.

Payer and Health System Consolidation: An Upward Trend

As consolidation increases, so too does payer and organized provider buying power. More than ever, biopharmaceutical manufacturers must demonstrate the economic and clinical value of their products. Take a closer look at some of the recent consolidations and how they might impact drug access, coverage, and reimbursement.

Measuring What Matters: Paying Attention to Patient Perspective in Drug Development

Pharmaceutical companies face many challenges: developing life-changing products that meet the needs of patients, physicians, and payers; adhering to regulatory standards; and managing health technology and payer scrutiny—all while trying to satisfy investors. Dominic Galante, chief medical officer with our Quality and Population Health Solutions team, makes the case that the patient perspective on value has never been more important.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.